Patents by Inventor Sharona Shachan-Tov

Sharona Shachan-Tov has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Crystalline form E1 of larotrectinib ethanesulfonate
    Patent number: 11339164
    Abstract: Salts and solid state forms of Larotrectinib, processes for preparation thereof, pharmaceutical compositions thereof, and uses thereof are disclosed.
    Type: Grant
    Filed: October 31, 2018
    Date of Patent: May 24, 2022
    Assignee: ASSIA CHEMICAL INDUSTRIES LTD.
    Inventors: Sharona Shachan-Tov, Doron Rudik, Oshrat Frenkel, Rotem Sella-Erez, Maytal Piran, Ido Fuchs
  • SOLID STATE FORMS OF VALBENAZINE
    Publication number: 20220127259
    Abstract: Solid state forms of Valbenazine, Valbenazine salts, processes for preparation thereof and pharmaceutical compositions thereof are disclosed. Processes for the preparation of Valbenazine and intermediates in the preparation thereof are further described.
    Type: Application
    Filed: January 5, 2022
    Publication date: April 28, 2022
    Inventors: Ariel Mittelman, Sharona Shachan-Tov, Abed Masarwa, Rotem Sella-Erez, Jonathan Enav, Motti Erlich, Victoria Machtey, Maytal Piran, Marina Yarovoy, Sagit Azran, Einat Kisin-Finfer, Tamar Nidam
  • Solid state forms of valbenazine
    Patent number: 11242341
    Abstract: Solid state forms of Valbenazine, Valbenazine salts, processes for preparation thereof and pharmaceutical compositions thereof are disclosed. Processes for the preparation of Valbenazine and intermediates in the preparation thereof are further described.
    Type: Grant
    Filed: October 6, 2017
    Date of Patent: February 8, 2022
    Assignee: ASSIA CHEMICAL INDUSTRIES LTD.
    Inventors: Ariel Mittelman, Sharona Shachan-Tov, Abed Masarwa, Rotem Sella-Erez, Jonathan Enav, Motti Erlich, Victoria Machtey, Maytal Piran, Marina Yarovoy, Sagit Azran, Einat Kisin-Finfer, Tamar Nidam
  • SALTS AND SOLID STATE FORMS OF LAROTRECTINIB
    Publication number: 20200255435
    Abstract: Salts and solid state forms of Larotrectinib, processes for preparation thereof, pharmaceutical compositions thereof, and uses thereof are disclosed.
    Type: Application
    Filed: October 31, 2018
    Publication date: August 13, 2020
    Applicants: ASSIA CHEMICAL INDUSTRIES LTD., ASSIA CHEMICAL INDUSTRIES LTD.
    Inventors: Sharona Shachan-Tov, Doron Rudik, Oshrat Frenkel, Rotem Sella-Erez, Maytal Piran, Ido Fuchs
  • Solid state forms of netarsudil mesylate
    Patent number: 10584100
    Abstract: Disclosed are solid state forms of Netarsudil mesylate, processes for preparation thereof, uses thereof, and pharmaceutical compositions thereof.
    Type: Grant
    Filed: September 4, 2019
    Date of Patent: March 10, 2020
    Assignee: ASSIA CHEMICAL INDUSTRIES LTD.
    Inventors: Alexander Mainfeld, Sharona Shachan-tov, Ariel Mittelman, Rotem Sella-Erez, Yifat Ronen, Tamar Nidam
  • SOLID STATE FORMS OF VALBENAZINE
    Publication number: 20200048244
    Abstract: Solid state forms of Valbenazine, Valbenazine salts, processes for preparation thereof and pharmaceutical compositions thereof are disclosed. Processes for the preparation of Valbenazine and intermediates in the preparation thereof are further described.
    Type: Application
    Filed: October 6, 2017
    Publication date: February 13, 2020
    Inventors: Ariel Mittelman, Sharona Shachan-Tov, Abed Masarwa, Rotem Sella-Erez, Jonathan Enav, Motti Erlich, Victoria Machtey, Maytal Piran, Marina Yarovoy, Sagit Azran, Einat Kisin-Finfer, Tamar Nidam
  • SOLID STATE FORMS OF NETARSUDIL MESYLATE
    Publication number: 20190389807
    Abstract: Disclosed are solid state forms of Netarsudil mesylate, processes for preparation thereof, uses thereof, and pharmaceutical compositions thereof.
    Type: Application
    Filed: September 4, 2019
    Publication date: December 26, 2019
    Inventors: Alexander Mainfeld, Sharona Shachan-tov, Ariel Mittelman, Rotem Sella-Erez, Yifat Ronen, Tamar Nidam
  • Solid state forms of netarsudil mesylate
    Patent number: 10442770
    Abstract: Disclosed are solid state forms of Netarsudil mesylate, processes for preparation thereof, uses thereof, and pharmaceutical compositions thereof.
    Type: Grant
    Filed: February 1, 2018
    Date of Patent: October 15, 2019
    Assignee: ASSIA CHEMICAL INDUSTRIES LTD.
    Inventors: Alexander Mainfeld, Sharona Shachan-tov, Ariel Mittelman, Rotem Sella-Erez, Yifat Ronen, Tamar Nidam
  • SOLID STATE FORMS OF NETARSUDIL MESYLATE
    Publication number: 20180215715
    Abstract: Disclosed are solid state forms of Netarsudil mesylate, processes for preparation thereof, uses thereof, and pharmaceutical compositions thereof.
    Type: Application
    Filed: February 1, 2018
    Publication date: August 2, 2018
    Inventors: Alexander Mainfeld, Sharona Shachan-tov, Ariel Mittelman, Rotem Sella-Erez, Yifat Ronen, Tamar Nidam
  • Crystal forms of O-desmethylvenlafaxine fumarate
    Patent number: 8063250
    Abstract: Provided are crystalline forms of O-desmethylvenlafaxine fumarate, methods for their preparation, and pharmaceutical compositions thereof.
    Type: Grant
    Filed: November 26, 2008
    Date of Patent: November 22, 2011
    Assignee: Teva Pharmaceutical Industries, Ltd.
    Inventors: Valerie Niddam-Hildesheim, Eli Lancry, Sharona Shachan-tov, Sigalit Levi, Tamar Nidam
  • Processes for the synthesis of O-desmethylvenlafaxine
    Patent number: 7605290
    Abstract: The present invention describes processes for the preparation of O-desmethylvenlafaxine and tridesmethylvenlafaxine, which may be used as an intermediate in preparing O-desmethylvenlafaxine.
    Type: Grant
    Filed: July 26, 2007
    Date of Patent: October 20, 2009
    Assignee: Teva Pharmaceutical Industries Ltd.
    Inventors: Valerie Niddam-Hildesheim, Natalia Shenkar, Sharona Shachan-Tov
  • Processes for the preparation of odesmethylvenlafaxine, free from its dimer impurities
    Publication number: 20090234020
    Abstract: The present invention provides isolated O-desmethylvenlafaxine impurities ODV-Dimer and ODV-N-Dimer, their use as a reference marker and reference standard, and a process for the preparation of O-desmethylvenlafaxine free from said impurities
    Type: Application
    Filed: March 6, 2009
    Publication date: September 17, 2009
    Inventors: Valarie Niddam-Hildesheim, Tamar Nidam, Yuri Vollerner, Miri Adler, Miri Kravitz, Sharona Shachan-tov
  • Crystal forms of O-desmethylvenlafaxine fumarate
    Publication number: 20090170948
    Abstract: Provided are crystalline forms of O-desmethylvenlafaxine fumarate, methods for their preparation, and pharmaceutical compositions thereof.
    Type: Application
    Filed: November 26, 2008
    Publication date: July 2, 2009
    Inventors: Valerie Niddam-Hildesheim, Eli Lancry, Sharona Shachan-tov, Sigalit Levi, Tamar Nidam
  • Process for the preparation of Retapamulin and its intermediates
    Publication number: 20090149655
    Abstract: Processes for preparing tropine derivatives of the following Formula B are provided where LG represents a leaving group. The tropine derivatives may be used to prepare Retapamulin, preferably in substantially pure form.
    Type: Application
    Filed: December 5, 2008
    Publication date: June 11, 2009
    Inventors: Lilach Hedvati, Eyal Gilboa, Sharon Avhar-Maydan, Sharona Shachan-Tov
  • Processes for preparing solid states of O-desmethylvenlafaxine succinate
    Publication number: 20080234516
    Abstract: Provided are processes for the preparation of amorphous O-desmethylvenlafaxine and for the preparation of crystalline forms I, II, III, and IV of O-desmethylvenlafaxine.
    Type: Application
    Filed: March 14, 2008
    Publication date: September 25, 2008
    Inventors: Valerie Niddam-Hildesheim, Sharona Shachan-Tov, Yaron Shmuely, Tamar Nidam, Alexandr Jegorov
  • Processes for the synthesis of O-desmethylvenlafaxine
    Publication number: 20080139849
    Abstract: The present invention describes processes for the preparation of O-desmethylvenlafaxine and tridesmethylvenlafaxine, which may be used as an intermediate in preparing O-desmethylvenlafaxine.
    Type: Application
    Filed: July 26, 2007
    Publication date: June 12, 2008
    Inventors: Valerie Niddam-Hildesheim, Natalia Shenkar, Sharona Shachan-Tov